Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Internal Medicine Journal|October 4, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based studyAmy Kang, Louisa Sukkar, Carinna Hockham, et al.
Plos One|July 25, 2022
Empowering faculty to initiate STEM education transformation: Efficacy of a systems thinking approachStasinos Stavrianeas, Gita Bangera, Claire Bronson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2023
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE TrialSjoukje van der Hoek, Niels Jongs, Megumi Oshima, et al.
American Journal of Nephrology|August 22, 2024
The Lived Experience of Patients with Chronic Kidney Disease: Insights From DISCOVER CKDCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.
Kidney International Reports|February 12, 2024
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A <i>Post Hoc</i> Analysis of CREDENCE TrialAkihiko Koshino, Brendon L Neuen, Megumi Oshima, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trialMegumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Advances in Therapy|July 3, 2024
Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective CohortHiddo Heerspink, Stephen Nolan, Juan-Jesus Carrero, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome TrialsMegumi Oshima, Luke Buizen, Niels Jongs, et al.
Pageof 16